StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 7/30
$34.07−0.32 (-0.93%)

Close on Nov 18, 2026Market cap $2.25BP/E 6.3Yield –

Lakefront Biotherapeutics total assets

Total assets on the balance sheet at the end of each period.

Lakefront Biotherapeutics's total assets was €3.41B at Dec 31, 2025. For fiscal 2025 it was €3.41B, down 17.6% from the year before. Over ten years it grew 22.6% a year on average. The highest annual figure on record is €6.07B in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025€3.41B-17.6%
FY2024Dec 31, 2024€4.14B-5.1%
FY2023Dec 31, 2023€4.36B-8.0%
FY2022Dec 31, 2022€4.73B-8.8%
FY2021Dec 31, 2021€5.19B-9.2%
FY2020Dec 31, 2020€5.72B-5.8%
FY2019Dec 31, 2019€6.07B+321.6%
FY2018Dec 31, 2018€1.44B+11.9%
FY2017Dec 31, 2017€1.29B+18.7%
FY2016Dec 31, 2016€1.08B+144.8%
FY2015Dec 31, 2015€442.51M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025€3.41B-34.4%
Q4 FY2024Dec 31, 2024€4.14B-23.8%
Q4 FY2023Dec 31, 2023€4.36B-23.8%
Q4 FY2022Dec 31, 2022€4.73B-19.1%
Q4 FY2021Dec 31, 2021€5.19B-14.4%
Q2 FY2021Jun 30, 2021€5.43B+299.9%
Q4 FY2020Dec 31, 2020€5.72B+297.2%
Q2 FY2020Jun 30, 2020€5.85B+385.9%
Q4 FY2019Dec 31, 2019€6.07B+371.8%
Q2 FY2019Jun 30, 2019€1.36B+25.3%
Q4 FY2018Dec 31, 2018€1.44B+225.3%
Q2 FY2018Jun 30, 2018€1.20B–
Q4 FY2017Dec 31, 2017€1.29B–
Q4 FY2016Dec 31, 2016€1.08B–
Q4 FY2015Dec 31, 2015€442.51M–

More Lakefront Biotherapeutics figures

See a number that looks wrong?